Annual SG&A:
$0.00-$249.75M(-100.00%)Summary
- As of today, RPRX annual SG&A is $0.00, with the most recent change of -$249.75 million (-100.00%) on December 31, 2024.
- During the last 3 years, RPRX annual SG&A has fallen by -$182.83 million (-100.00%).
- RPRX annual SG&A is now -100.00% below its all-time high of $249.75 million, reached on December 31, 2023.
Performance
RPRX SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$179.77M(-100.00%)Summary
- As of today, RPRX quarterly SG&A is $0.00, with the most recent change of -$179.77 million (-100.00%) on September 30, 2025.
- Over the past year, RPRX quarterly SG&A has dropped by -$56.72 million (-100.00%).
- RPRX quarterly SG&A is now -100.00% below its all-time high of $179.77 million, reached on June 30, 2025.
Performance
RPRX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
$9.85B-$460.37M(-4.46%)Summary
- As of today, RPRX TTM SG&A is $9.85 billion, with the most recent change of -$460.37 million (-4.46%) on September 30, 2025.
- Over the past year, RPRX TTM SG&A has increased by +$9.63 billion (+4220.14%).
- RPRX TTM SG&A is now -5.88% below its all-time high of $10.47 billion.
Performance
RPRX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
RPRX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -100.0% | -100.0% | +4220.1% |
| 3Y3 Years | -100.0% | -100.0% | +4824.8% |
| 5Y5 Years | -100.0% | -100.0% | +6271.1% |
RPRX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -100.0% | at low | -100.0% | at low | -5.9% | +15.0% |
| 5Y | 5-Year | -100.0% | at low | -100.0% | at low | -5.9% | +36.4% |
| All-Time | All-Time | -100.0% | at low | -100.0% | at low | -5.9% | +248.8% |
RPRX Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $0.00(-100.0%) | $358.47M(-13.7%) |
| Jun 2025 | - | $179.77M(+62.4%) | $415.19M(+43.1%) |
| Mar 2025 | - | $110.70M(+62.8%) | $290.13M(+22.4%) |
| Dec 2024 | $0.00(-100.0%) | $68.00M(+19.9%) | $237.08M(+3.9%) |
| Sep 2024 | - | $56.72M(+3.7%) | $228.08M(-0.2%) |
| Jun 2024 | - | $54.71M(-5.1%) | $228.59M(+3.2%) |
| Mar 2024 | - | $57.65M(-2.3%) | $221.52M(-11.2%) |
| Dec 2023 | $249.75M(+9.9%) | $59.00M(+3.1%) | $249.56M(-5.3%) |
| Sep 2023 | - | $57.23M(+20.2%) | $263.56M(+2.5%) |
| Jun 2023 | - | $47.63M(-44.4%) | $257.02M(-1.6%) |
| Mar 2023 | - | $85.69M(+17.4%) | $261.23M(+15.0%) |
| Dec 2022 | $227.30M(+24.3%) | $73.00M(+44.0%) | $227.07M(+13.5%) |
| Sep 2022 | - | $50.69M(-2.2%) | $200.07M(+1.1%) |
| Jun 2022 | - | $51.84M(+0.6%) | $197.97M(+3.6%) |
| Mar 2022 | - | $51.54M(+12.0%) | $191.05M(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $182.83M(+0.6%) | $46.00M(-5.3%) | $182.66M(-2.1%) |
| Sep 2021 | - | $48.59M(+8.2%) | $186.66M(-1.1%) |
| Jun 2021 | - | $44.92M(+4.1%) | $188.81M(+1.1%) |
| Mar 2021 | - | $43.16M(-13.7%) | $186.69M(+2.8%) |
| Dec 2020 | $181.72M(+75.7%) | $50.00M(-1.4%) | $181.60M(+17.4%) |
| Sep 2020 | - | $50.73M(+18.5%) | $154.66M(+19.4%) |
| Jun 2020 | - | $42.80M(+12.4%) | $129.53M(+10.6%) |
| Mar 2020 | - | $38.06M(+65.1%) | $117.08M(+13.2%) |
| Dec 2019 | $103.44M(+67.1%) | $23.06M(-9.9%) | $103.44M(+28.7%) |
| Sep 2019 | - | $25.60M(-15.6%) | $80.38M(+46.7%) |
| Jun 2019 | - | $30.35M(+24.2%) | $54.77M(+124.2%) |
| Mar 2019 | - | $24.43M | $24.43M |
| Dec 2018 | $61.91M(-41.8%) | - | - |
| Dec 2017 | $106.44M(+53.1%) | - | - |
| Dec 2016 | $69.51M(-42.7%) | - | - |
| Dec 2015 | $121.42M | - | - |
FAQ
- What is Royalty Pharma plc annual SG&A?
- What is the all-time high annual SG&A for Royalty Pharma plc?
- What is Royalty Pharma plc annual SG&A year-on-year change?
- What is Royalty Pharma plc quarterly SG&A?
- What is the all-time high quarterly SG&A for Royalty Pharma plc?
- What is Royalty Pharma plc quarterly SG&A year-on-year change?
- What is Royalty Pharma plc TTM SG&A?
- What is the all-time high TTM SG&A for Royalty Pharma plc?
- What is Royalty Pharma plc TTM SG&A year-on-year change?
What is Royalty Pharma plc annual SG&A?
The current annual SG&A of RPRX is $0.00
What is the all-time high annual SG&A for Royalty Pharma plc?
Royalty Pharma plc all-time high annual SG&A is $249.75M
What is Royalty Pharma plc annual SG&A year-on-year change?
Over the past year, RPRX annual SG&A has changed by -$249.75M (-100.00%)
What is Royalty Pharma plc quarterly SG&A?
The current quarterly SG&A of RPRX is $0.00
What is the all-time high quarterly SG&A for Royalty Pharma plc?
Royalty Pharma plc all-time high quarterly SG&A is $179.77M
What is Royalty Pharma plc quarterly SG&A year-on-year change?
Over the past year, RPRX quarterly SG&A has changed by -$56.72M (-100.00%)
What is Royalty Pharma plc TTM SG&A?
The current TTM SG&A of RPRX is $9.85B
What is the all-time high TTM SG&A for Royalty Pharma plc?
Royalty Pharma plc all-time high TTM SG&A is $10.47B
What is Royalty Pharma plc TTM SG&A year-on-year change?
Over the past year, RPRX TTM SG&A has changed by +$9.63B (+4220.14%)